We are live on ! Find out more
Bessemer Group

Bessemer Group Portfolio holdings

AUM $63.6B
1-Year Est. Return 28.76%
This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$45.5B
AUM Growth
-$1.58B
Cap. Flow
+$318M
Cap. Flow %
0.7%
Top 10 Hldgs %
27.97%
Holding
2,413
New
127
Increased
815
Reduced
772
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Financials 12.55%
3 Healthcare 11.02%
4 Consumer Discretionary 9.59%
5 Industrials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AU icon
301
AngloGold Ashanti
AU
$39.9B
$7.55M 0.02%
+478,145
New +$9.03M
TCBI icon
302
Texas Capital Bancshares
TCBI
$4.29B
$7.54M 0.02%
128,068
+5,749
+5% +$348K
IBM icon
303
IBM
IBM
$214B
$7.48M 0.02%
53,334
+1,596
+3% +$227K
MYRG icon
304
MYR Group
MYRG
$5.31B
$7.43M 0.02%
55,124
+13,665
+33% +$1.93M
PFE icon
305
Pfizer
PFE
$144B
$7.43M 0.02%
223,928
-14,069
-6% -$498K
ENV
306
DELISTED
ENVESTNET, INC.
ENV
$7.28M 0.02%
165,383
+7,326
+5% +$402K
BZ icon
307
Kanzhun
BZ
$7.07B
$7.28M 0.02%
479,845
-65,551
-12% -$1.03M
AZN icon
308
AstraZeneca
AZN
$267B
$7.28M 0.02%
53,707
-5,533
-9% -$756K
ESGU icon
309
iShares ESG Aware MSCI USA ETF
ESGU
$17.8B
$7.27M 0.02%
77,464
AMGN icon
310
Amgen
AMGN
$212B
$7.26M 0.02%
27,003
+2,442
+10% +$609K
NVO
311
Novo Nordisk
NVO
$225B
$7.04M 0.02%
77,442
+4,096
+6% +$361K
IDXX icon
312
Idexx Laboratories
IDXX
$44.9B
$7.03M 0.02%
16,070
+879
+6% +$438K
AZEK
313
DELISTED
The AZEK Co
AZEK
$6.97M 0.02%
234,554
+57,260
+32% +$1.8M
FORM icon
314
FormFactor
FORM
$6.88B
$6.94M 0.02%
198,621
+56,491
+40% +$1.9M
GILD icon
315
Gilead Sciences
GILD
$167B
$6.88M 0.02%
91,867
+26,381
+40% +$2.03M
FLR icon
316
Fluor
FLR
$6.89B
$6.87M 0.02%
187,186
+186,520
+28,006% +$6.25M
PNFP icon
317
Pinnacle Financial Partners Inc
PNFP
$15.9B
$6.82M 0.02%
101,693
-505
-0.5% -$34.1K
AMPH icon
318
Amphastar Pharmaceuticals
AMPH
$888M
$6.81M 0.02%
148,144
+147,824
+46,195% +$8.06M
RPC
319
Ridgepost Capital
RPC
$971M
$6.8M 0.01%
583,785
+27,349
+5% +$320K
RVMD icon
320
Revolution Medicines
RVMD
$39.1B
$6.74M 0.01%
243,442
-199,000
-45% -$5.9M
CI icon
321
Cigna
CI
$79.6B
$6.72M 0.01%
23,476
-19
-0.1% -$5.42K
CVBF icon
322
CVB Financial
CVBF
$4.02B
$6.67M 0.01%
402,537
+18,818
+5% +$319K
STVN icon
323
Stevanato
STVN
$5.5B
$6.66M 0.01%
223,994
-43,776
-16% -$1.37M
PAG icon
324
Penske Automotive Group
PAG
$14.5B
$6.39M 0.01%
38,245
+11,758
+44% +$1.97M
VCIT icon
325
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.4B
$6.15M 0.01%
80,914
-23,902
-23% -$1.86M

Similar funds

Bessemer Group's Q3 2023 Portfolio in Review

As of Q3 2023, Bessemer Group held 2,413 positions worth $45.5B, down 3.4% from $47.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bessemer Group's Q3 2023 filing shows 127 new, 815 increased, 772 reduced and 222 closed positions. Its largest new stake was Kenvue: 4,178,458 shares worth $83.9M. The largest sale was Texas Instruments, an estimated $178M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Bessemer Group's largest Q3 2023 buy was Kenvue: 4,178,458 shares worth $83.9M.
  • Bessemer Group added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2023, an estimated $182M increase.
  • Bessemer Group's biggest Q3 2023 reduction was Texas Instruments, cutting an estimated $178M.
  • Bessemer Group fully exited Delek US in Q3 2023, selling an estimated $3.97M.
  • Bessemer Group's ten largest holdings make up 28% of its $45.5B portfolio in Q3 2023.
  • Bessemer Group opened 127 new positions and closed 222 in Q3 2023.
  • Bessemer Group's portfolio value fell 3.4% quarter-over-quarter to $45.5B.

Based on Bessemer Group's 13F filing for Q3 2023, filed 13 Nov 2023.